Our summary
In response to COVID-19, US regulators expanded telemedicine coverage for Medicare beneficiaries, soon adopted by public and private insurers, allowing remote cancer care. While in-person visits declined, telemedicine surged to 15-25% at cancer centers. However, national surveys suggest uneven use based on race, ethnicity, and socioeconomic factors.
In this study, researchers investigated inequities in telemedicine use among US patients starting treatment for 20 common cancers at community centers during COVID-19.
Why this matters
This study's findings showcase the potential for exacerbated inequities surrounding telemedicine if equitable access isn't ensured for people of color and marginalized communities. This is particularly relevant as discussions about continuing telemedicine after the COVID-19 emergency are ongoing. While efforts thus far have focused on insurance coverage and reimbursement, this study highlights the necessity of addressing barriers rooted in patients' social determinants of health.